Avanir Targets Impax Over Generic Nuedexta Plans
Avanir Pharmaceuticals Inc. on Monday sued rival Impax Laboratories Inc. in Delaware federal court, claiming Impax's plans to make a generic version of involuntary-emotion drug Nuedexta infringe one of its patents....To view the full article, register now.
Already a subscriber? Click here to view full article